IP Library Granted Patent US 8,597,691
Granted Patent B2
US 8,597,691 · App. 12/581,428 · Granted Dec 3, 2013

Anti-hypothermia composition

Inventors: Kazunori Satou (Shizuoka, JP); Takashi Ogawa (Shizuoka, JP); Saori Mori (Shizuoka, JP)
Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,691
App. No.
12/581,428
Granted
Dec 3, 2013
Kind
B2
Abstract

An anti-hypothermia composition is provided, in particular an anti-hypothermia composition that prevents hypothermia caused by general anesthesia during surgical operations. The composition prevents hypothermia by preventing the decrease in the biological function of patients and correcting acidosis. Specifically, the anti-hypothermia composition is a preparation containing a bicarbonate ion and provided in the form of an infusion fluid. The infusion fluid preferably contains sodium bicarbonate as a major component that serves as a source of the bicarbonate ion, along with each or a combination of other electrolytes, glucose and amino acids.

Claims (10)

1. A method of ameliorating hypothermia in a patient receiving propofol, comprising administering to the patient an effective amount Bicarbonate-Ringer's solution.

2. The method of claim 1 , wherein the Bicarbonated-Ringer's solution does not contain amino acids.

3. The method of claim 1 , wherein the concentration of the bicarbonate ion in the solution is 20 to 40 mEq/L.

4. The method of claim 1 , wherein the concentration of the bicarbonate ion in the solution is 22 to 30 mEq/L.

5. The method of claim 1 , wherein the patient is undergoing a surgical procedure.

6. The method of claim 1 , wherein administering the solution also corrects acidosis in the patient.

7. The method of claim 1 , wherein the solution contains 130-145 mEq/L of sodium ion, 2-5 mEq/L of potassium ion, 90-130 mEq/L of chloride ion, 2-5 mEq/L of calcium ion, 0.5-2.5 mEq/L of magnesium ion, 0-7 mEq/L of citrate ion and 0-5 g/L of glucose.

8. The method of claim 1 , wherein the solution comprises sodium bicarbonate as a major component that serves as a source of the bicarbonate ion, along with one or more other electrolytes and/or glucose.

9. The method of claim 8 , wherein said other electrolyte(s) comprises One or more of sodium chloride, sodium citrate, sodium acetate, sodium lactate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium gluconate, sodium glycerophosphate, sodium malate, potassium chloride, dibasic potassium phosphate, potassium acetate, potassium citrate, potassium lactate, potassium glycerophosphate, potassium malate, calcium chloride, calcium lactate, calcium gluconate, calcium glycerophosphate, dibasic calcium phosphate, calcium malate, magnesium chloride, magnesium gluconate, and magnesium glycerophosphate.

10. The method of claim 9 , the solution contains one or more of sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium citrate and glucose.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2009
From: SATOU, KAZUNORI; OGAWA, TAKASHI; MORI, SAORI
To: AJINOMOTO CO., INC.
Reel/Frame 023642/0974 →
Priority Claims (1)
JP 2007-111895 · Apr 20, 2007 · national
Continuity (2)
Continuation PCTJP2008057467 · Apr 17, 2008
Related Publication 20100080858A1 · Apr 1, 2010